Bio-Rad Laboratories, Inc. (FRA:BUW)

Germany flag Germany · Delayed Price · Currency is EUR
228.00
0.00 (0.00%)
At close: Dec 4, 2025
-25.00%
Market Cap 7.36B
Revenue (ttm) 2.18B
Net Income (ttm) -576.07M
Shares Out n/a
EPS (ttm) -20.93
PE Ratio n/a
Forward PE 30.97
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume n/a
Open 228.00
Previous Close 228.00
Day's Range 228.00 - 228.00
52-Week Range 206.00 - 332.00
Beta n/a
RSI 51.15
Earnings Date Feb 13, 2026

About Bio-Rad Laboratories

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials, such as cells, proteins, and nucleic acids used in biopharmaceutical manufacturing, quality control process, food safety, and science e... [Read more]

Industry Laboratory Analytical Instruments
Founded 1952
Employees 7,700
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol BUW
Full Company Profile

Financial Performance

In 2024, Bio-Rad Laboratories's revenue was $2.57 billion, a decrease of -3.92% compared to the previous year's $2.67 billion. Losses were -$1.84 billion, 189.4% more than in 2023.

Financial numbers in USD Financial Statements

News

There is no news available yet.